529 - 540 of 7281 results
0.5 CME CREDIT

This presentation will cover the latest scientific information regarding screening, assessment, and office-based management for alcohol use disorders. Specifically, the faculty will emphasize how to engage and motivate patients with risky drinking to change their behaviors. You will review use of current FDA-approved medications for alcohol use disorders and office-based psychotherapy techniques that primary care providers can effectively deliver. Finally, the faculty will discuss placement criteria focused on knowing when to refer patients to intensive outpatient programs and what to expect in residential treatments programs.


1 CME CREDIT

This presentation will use case-based scenarios to illustrate different patterns of liver test abnormalities. The faculty will discuss the difference between cholestatic versus hepatitis versus infiltrative liver diseases and their characteristic liver test patterns. You will learn about the workup of liver test abnormalities with subsequent supplemental serological testing, imaging, and in some cases, liver biopsy. After this session, you will know the difference between true “liver function tests,” tests of cholestasis, tests of inflammation, and tests of infiltration.


1 CME CREDIT

This talk will focus on the central importance of power differentials in relationships and the role of power and control in intimate partner violence (IPV). The speaker will outline the identifying signs and symptoms of abuse and discuss techniques for screening for IPV during office visits. Participants will review opportunities and methods for developing safety plans and providing emotional, legal, and medical support to patients when IPV has been identified. The #MeToo movement is an empowering catalyst for victims to speak out about abuse; we as providers are in a unique and privileged position to support and advocate for these deserving patients. This online activity is approved by the Florida Board of Nursing for APRNs, for 1 hour on Domestic Violence (approved as of 2/11/20). This activity meets the criteria of the Florida Board of Medicine; approval is not required. CE Broker Provider #50-27480, Activity #20-688617


1.25 CME CREDITS

This session will provide a clear, thoughtful approach to shoulder pain and offer pearls for rapid diagnosis and management. Key concepts will include a review of important structures around the shoulder that can cause pain and the positive impact of ergonomics. The speaker will also discuss decision-making for management and referral.


0.75 CME CREDIT

This talk will review issues surrounding C. difficile and transmission prevention. After a thorough discussion on antibiotic therapy, the speaker will evaluate the increased use of fecal microbiota transplant (FMT) in recurrent C. difficile treatment and expand on potential extended applications of the procedure.


0.25 CME CREDIT

During this session (part 1 of 3 webcast videos), Dr. Tina Thethi reviews the association between type 2 diabetes and cardiovascular disease as well as provides an overview of the American Diabetes Association guidelines designed to help individualize therapy for patients with T2DM and concurrent heart failure and/or atherosclerotic cardiovascular disease. *Please note that any data, indications and guidelines presented in this activity are current as of the original recording on 12/3/2019, and they are subject to change as new information is published.


0.75 CME CREDIT

The faculty will provide an overview and update of irritable bowel syndrome (IBS), including the new Rome IV diagnostic criteria, pathophysiology and pharmacologic and non-pharmacologic treatment approaches. The lecture will review the new Rome multidimensional clinical disease profiles (MDCP), which helps to characterize the unique profile of a FGID patient with a classification of diagnosis, clinical modifiers, psychological symptoms, quality of life, and biomarkers that help to guide treatment.


0.75 CME CREDIT

Chronic kidney disease stage III represents significant renal insufficiency and carries an increased risk of mortality and morbidity. The talk will discuss the determination of CKD categories, their clinical implications, and appropriate testing and monitoring. Participants will receive an in-depth look at outcomes and strategies for preventing progression of renal insufficiency and review the appropriate time for consultation with a renal specialist.


0.75 CME CREDIT

Memory loss is a common complaint across the age spectrum. This presentation will give a practical and cost-effective approach to assessing memory loss in the primary care setting.


0.75 CME CREDIT

Clinicians confront ongoing and increasingly complex challenges around delivering immunization in their practice. Vaccine hesitancy among patients, conflicting "messaging" about the need, efficacy, and appropriate scheduling of certain vaccines in the lay and medical press as well as issues related to financing of vaccination efforts in the office setting and ongoing changes in official vaccine recommendations all contribute to this challenge. The speaker will discuss contemporary issues related to addressing vaccine delivery including 1) understanding the science of vaccines and vaccine safety and effectiveness, 2) reviewing the latest vaccine recommendations, and 3) learning simple, yet effective and time-efficient strategies to overcome vaccine hesitancy in the office.


0.75 CME CREDIT

This is a clinical bedside approach to treating the patient with multiple aches and pains based on the target of inflammation in the joint and the distribution of affected joints. Using this approach, we can sort out non-inflammatory arthritis as represented by osteoarthritis from inflammatory synovitis (rheumatoid arthritis), inflammatory enthesitis (ankylosing spondylitis, psoriatic arthritis), and non-inflammatory rheumatic conditions like fibromyalgia. The use of X-rays, ultrasound, and MRI, and common laboratory studies like ESR, CRP, rheumatoid factor, anti-CCP, and ANA will be discussed.


0.75 CME CREDIT

The antinuclear antibody (ANA) test is the single most famous test in rheumatology; yet, it is frequently misused and misinterpreted. This talk will discuss the different ways the test is performed and interpreted, and how it can be properly applied to the diagnosis of lupus and other autoimmune diseases. The speaker will show how antinuclear antibodies can cause tissue damage and result in the clinical features of lupus. Then, learners will review the many non-rheumatic conditions, including healthy individuals, who may have a positive ANA and how we should sort them.